These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 29125504)

  • 1. Clinical Outcomes in Duchenne Muscular Dystrophy: A Study of 5345 Patients from the TREAT-NMD DMD Global Database.
    Koeks Z; Bladen CL; Salgado D; van Zwet E; Pogoryelova O; McMacken G; Monges S; Foncuberta ME; Kekou K; Kosma K; Dawkins H; Lamont L; Bellgard MI; Roy AJ; Chamova T; Guergueltcheva V; Chan S; Korngut L; Campbell C; Dai Y; Wang J; Barišić N; Brabec P; Lähdetie J; Walter MC; Schreiber-Katz O; Karcagi V; Garami M; Herczegfalvi A; Viswanathan V; Bayat F; Buccella F; Ferlini A; Kimura E; van den Bergen JC; Rodrigues M; Roxburgh R; Lusakowska A; Kostera-Pruszczyk A; Santos R; Neagu E; Artemieva S; Rasic VM; Vojinovic D; Posada M; Bloetzer C; Klein A; Díaz-Manera J; Gallardo E; Karaduman AA; Oznur T; Topaloğlu H; El Sherif R; Stringer A; Shatillo AV; Martin AS; Peay HL; Kirschner J; Flanigan KM; Straub V; Bushby K; Béroud C; Verschuuren JJ; Lochmüller H
    J Neuromuscul Dis; 2017; 4(4):293-306. PubMed ID: 29125504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. European Cross-Sectional Survey of Current Care Practices for Duchenne Muscular Dystrophy Reveals Regional and Age-Dependent Differences.
    Vry J; Gramsch K; Rodger S; Thompson R; Steffensen BF; Rahbek J; Doerken S; Tassoni A; Beytía ML; Guergueltcheva V; Chamova T; Tournev I; Kostera-Pruszczyk A; Kaminska A; Lusakowska A; Mrazova L; Pavlovska L; Strenkova J; Vondráček P; Garami M; Karcagi V; Herczegfalvi Á; Bushby K; Lochmüller H; Kirschner J
    J Neuromuscul Dis; 2016 Nov; 3(4):517-527. PubMed ID: 27911335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corticosteroids for the treatment of Duchenne muscular dystrophy.
    Matthews E; Brassington R; Kuntzer T; Jichi F; Manzur AY
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD003725. PubMed ID: 27149418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical course of Duchenne muscular dystrophy in the corticosteroid treatment era: a systematic literature review.
    Szabo SM; Salhany RM; Deighton A; Harwood M; Mah J; Gooch KL
    Orphanet J Rare Dis; 2021 May; 16(1):237. PubMed ID: 34022943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Early Care (0-3 Years) In Duchenne Muscular Dystrophy Meeting Report.
    Armstrong N; Apkon S; Berggren KN; Braun C; Ciafaloni E; Connolly A; Kennedy A; Kuntz N; Mathews K; McGuire M; Parad R; Scavina M; Scharf RJ; Waldrop M
    J Neuromuscul Dis; 2024; 11(2):525-533. PubMed ID: 38189762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The natural history of the patients with Duchenne muscular dystrophy in Taiwan: A medical center experience.
    Liang WC; Wang CH; Chou PC; Chen WZ; Jong YJ
    Pediatr Neonatol; 2018 Apr; 59(2):176-183. PubMed ID: 28903883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations between timing of corticosteroid treatment initiation and clinical outcomes in Duchenne muscular dystrophy.
    Kim S; Zhu Y; Romitti PA; Fox DJ; Sheehan DW; Valdez R; Matthews D; Barber BJ;
    Neuromuscul Disord; 2017 Aug; 27(8):730-737. PubMed ID: 28645460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The TREAT-NMD DMD Global Database: analysis of more than 7,000 Duchenne muscular dystrophy mutations.
    Bladen CL; Salgado D; Monges S; Foncuberta ME; Kekou K; Kosma K; Dawkins H; Lamont L; Roy AJ; Chamova T; Guergueltcheva V; Chan S; Korngut L; Campbell C; Dai Y; Wang J; Barišić N; Brabec P; Lahdetie J; Walter MC; Schreiber-Katz O; Karcagi V; Garami M; Viswanathan V; Bayat F; Buccella F; Kimura E; Koeks Z; van den Bergen JC; Rodrigues M; Roxburgh R; Lusakowska A; Kostera-Pruszczyk A; Zimowski J; Santos R; Neagu E; Artemieva S; Rasic VM; Vojinovic D; Posada M; Bloetzer C; Jeannet PY; Joncourt F; Díaz-Manera J; Gallardo E; Karaduman AA; Topaloğlu H; El Sherif R; Stringer A; Shatillo AV; Martin AS; Peay HL; Bellgard MI; Kirschner J; Flanigan KM; Straub V; Bushby K; Verschuuren J; Aartsma-Rus A; Béroud C; Lochmüller H
    Hum Mutat; 2015 Apr; 36(4):395-402. PubMed ID: 25604253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of Japanese Duchenne and Becker muscular dystrophy patients in a novel Japanese national registry of muscular dystrophy (Remudy).
    Nakamura H; Kimura E; Mori-Yoshimura M; Komaki H; Matsuda Y; Goto K; Hayashi YK; Nishino I; Takeda S; Kawai M
    Orphanet J Rare Dis; 2013 Apr; 8():60. PubMed ID: 23601510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corticosteroids in Duchenne muscular dystrophy: major variations in practice.
    Griggs RC; Herr BE; Reha A; Elfring G; Atkinson L; Cwik V; McColl E; Tawil R; Pandya S; McDermott MP; Bushby K
    Muscle Nerve; 2013 Jul; 48(1):27-31. PubMed ID: 23483575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time to diagnosis of Duchenne muscular dystrophy in Austria and Germany.
    Hiebeler M; Thiele S; Reilich P; Bernert G; Walter MC
    Sci Rep; 2023 Jan; 13(1):179. PubMed ID: 36604563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The TREAT-NMD Duchenne muscular dystrophy registries: conception, design, and utilization by industry and academia.
    Bladen CL; Rafferty K; Straub V; Monges S; Moresco A; Dawkins H; Roy A; Chamova T; Guergueltcheva V; Korngut L; Campbell C; Dai Y; Barišić N; Kos T; Brabec P; Rahbek J; Lahdetie J; Tuffery-Giraud S; Claustres M; Leturcq F; Ben Yaou R; Walter MC; Schreiber O; Karcagi V; Herczegfalvi A; Viswanathan V; Bayat F; de la Caridad Guerrero Sarmiento I; Ambrosini A; Ceradini F; Kimura E; van den Bergen JC; Rodrigues M; Roxburgh R; Lusakowska A; Oliveira J; Santos R; Neagu E; Butoianu N; Artemieva S; Rasic VM; Posada M; Palau F; Lindvall B; Bloetzer C; Karaduman A; Topaloğlu H; Inal S; Oflazer P; Stringer A; Shatillo AV; Martin AS; Peay H; Flanigan KM; Salgado D; von Rekowski B; Lynn S; Heslop E; Gainotti S; Taruscio D; Kirschner J; Verschuuren J; Bushby K; Béroud C; Lochmüller H
    Hum Mutat; 2013 Nov; 34(11):1449-57. PubMed ID: 23913485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The burden, epidemiology, costs and treatment for Duchenne muscular dystrophy: an evidence review.
    Ryder S; Leadley RM; Armstrong N; Westwood M; de Kock S; Butt T; Jain M; Kleijnen J
    Orphanet J Rare Dis; 2017 Apr; 12(1):79. PubMed ID: 28446219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interventions for preventing and treating cardiac complications in Duchenne and Becker muscular dystrophy and X-linked dilated cardiomyopathy.
    Bourke JP; Bueser T; Quinlivan R
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD009068. PubMed ID: 30326162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and mutational characteristics of Duchenne muscular dystrophy patients based on a comprehensive database in South China.
    Wang DN; Wang ZQ; Yan L; He J; Lin MT; Chen WJ; Wang N
    Neuromuscul Disord; 2017 Aug; 27(8):715-722. PubMed ID: 28318817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variables associated with upper extremity function in patients with Duchenne muscular dystrophy.
    Janssen MM; Hendriks JC; Geurts AC; de Groot IJ
    J Neurol; 2016 Sep; 263(9):1810-8. PubMed ID: 27314968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral corticosteroids and onset of cardiomyopathy in Duchenne muscular dystrophy.
    Barber BJ; Andrews JG; Lu Z; West NA; Meaney FJ; Price ET; Gray A; Sheehan DW; Pandya S; Yang M; Cunniff C
    J Pediatr; 2013 Oct; 163(4):1080-4.e1. PubMed ID: 23866715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DMD genotype correlations from the Duchenne Registry: Endogenous exon skipping is a factor in prolonged ambulation for individuals with a defined mutation subtype.
    Wang RT; Barthelemy F; Martin AS; Douine ED; Eskin A; Lucas A; Lavigne J; Peay H; Khanlou N; Sweeney L; Cantor RM; Miceli MC; Nelson SF
    Hum Mutat; 2018 Sep; 39(9):1193-1202. PubMed ID: 29907980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of disease progression and genetic correlation in ambulatory Iranian boys with Duchenne muscular dystrophy.
    Zamani G; Hosseinpour S; Ashrafi MR; Mohammadi M; Badv RS; Tavasoli AR; Akbari MG; Bereshneh AH; Malamiri RA; Heidari M
    BMC Neurol; 2022 May; 22(1):162. PubMed ID: 35501714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19 in advanced Duchenne/Becker muscular dystrophy patients.
    Levine H; Prais D; Aharoni S; Nevo Y; Katz J; Rahmani E; Goldberg L; Scheuerman O
    Neuromuscul Disord; 2021 Jul; 31(7):607-611. PubMed ID: 34053847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.